A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Boston Scientific Corp stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 945,391 shares of BSX stock, worth $85.5 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
945,391
Previous 931,678 1.47%
Holding current value
$85.5 Million
Previous $71.7 Million 10.42%
% of portfolio
0.37%
Previous 0.35%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$72.96 - $84.0 $1 Million - $1.15 Million
13,713 Added 1.47%
945,391 $79.2 Million
Q2 2024

Aug 13, 2024

SELL
$67.33 - $77.71 $12.5 Million - $14.5 Million
-185,963 Reduced 16.64%
931,678 $71.7 Million
Q1 2024

May 13, 2024

SELL
$57.6 - $68.62 $1.16 Million - $1.38 Million
-20,059 Reduced 1.76%
1,117,641 $76.5 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $2.89 Million - $3.44 Million
59,492 Added 5.52%
1,137,700 $65.8 Million
Q3 2023

Nov 09, 2023

SELL
$50.19 - $54.68 $331,806 - $361,489
-6,611 Reduced 0.61%
1,078,208 $56.9 Million
Q2 2023

Aug 07, 2023

BUY
$49.72 - $54.64 $988,185 - $1.09 Million
19,875 Added 1.87%
1,084,819 $58.7 Million
Q1 2023

May 11, 2023

SELL
$45.09 - $50.03 $2.88 Million - $3.19 Million
-63,790 Reduced 5.65%
1,064,944 $53.3 Million
Q4 2022

Feb 08, 2023

BUY
$39.56 - $47.22 $2.45 Million - $2.93 Million
61,948 Added 5.81%
1,128,734 $52.2 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $831,775 - $2.48 Million
-22,658 Reduced 2.08%
1,066,786 $41.3 Million
Q2 2022

Aug 10, 2022

BUY
$35.24 - $47.1 $5.83 Million - $7.79 Million
165,455 Added 17.91%
1,089,444 $40.6 Million
Q1 2022

May 11, 2022

BUY
$40.9 - $45.1 $24.4 Million - $26.9 Million
596,952 Added 182.53%
923,989 $40.9 Million
Q4 2021

Feb 10, 2022

SELL
$38.07 - $44.87 $53.3 Million - $62.8 Million
-1,398,991 Reduced 81.05%
327,037 $14.1 Million
Q3 2021

Nov 10, 2021

BUY
$41.23 - $45.88 $56.1 Million - $62.4 Million
1,359,727 Added 371.2%
1,726,028 $74.9 Million
Q2 2021

Aug 10, 2021

BUY
$38.58 - $44.24 $978,427 - $1.12 Million
25,361 Added 7.44%
366,301 $15.7 Million
Q1 2021

May 14, 2021

BUY
$35.27 - $39.67 $123,268 - $138,646
3,495 Added 1.04%
340,940 $13.2 Million
Q4 2020

Feb 11, 2021

SELL
$33.15 - $41.97 $35,669 - $45,159
-1,076 Reduced 0.32%
337,445 $12.1 Million
Q3 2020

Nov 12, 2020

BUY
$34.44 - $42.23 $1.73 Million - $2.12 Million
50,165 Added 17.4%
338,521 $12.9 Million
Q2 2020

Aug 13, 2020

SELL
$30.19 - $39.11 $972,782 - $1.26 Million
-32,222 Reduced 10.05%
288,356 $10.1 Million
Q1 2020

May 13, 2020

BUY
$25.83 - $45.71 $393,520 - $696,391
15,235 Added 4.99%
320,578 $10.5 Million
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $1.41 Million - $1.69 Million
37,243 Added 13.89%
305,343 $13.8 Million
Q3 2019

Nov 08, 2019

SELL
$40.31 - $43.45 $22,089 - $23,810
-548 Reduced 0.2%
268,100 $10.9 Million
Q2 2019

Aug 09, 2019

BUY
$34.91 - $42.98 $593,435 - $730,617
16,999 Added 6.76%
268,648 $11.5 Million
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $29,618 - $36,675
900 Added 0.36%
251,649 $9.66 Million
Q4 2018

Feb 12, 2019

BUY
$31.73 - $39.04 $559,463 - $688,353
17,632 Added 7.56%
250,749 $8.86 Million
Q3 2018

Nov 05, 2018

SELL
$32.83 - $38.63 $305,319 - $359,259
-9,300 Reduced 3.84%
233,117 $8.98 Million
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $2.02 Million - $2.58 Million
75,276 Added 45.04%
242,417 $7.93 Million
Q1 2018

Apr 30, 2018

SELL
$25.2 - $28.54 $1.93 Million - $2.19 Million
-76,763 Reduced 31.47%
167,141 $4.57 Million
Q4 2017

Feb 12, 2018

BUY
$24.79 - $29.8 $85,847 - $103,197
3,463 Added 1.44%
243,904 $6.05 Million
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $325,624 - $361,708
12,400 Added 5.44%
240,441 $7.01 Million
Q2 2017

Aug 14, 2017

BUY
N/A
228,041
228,041 $0

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.